Pharsight

Sun Pharm Inds Inc patents expiration

1. Ortikos patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9707182 SUN PHARM INDS INC Oral pharmaceutical dosage forms of budesonide
Sep, 2036

(12 years from now)

US10172802 SUN PHARM INDS INC Oral pharmaceutical dosage forms of budesonide
Sep, 2036

(12 years from now)

Drugs and Companies using BUDESONIDE ingredient

Market Authorisation Date: 13 June, 2019

Treatment: Treatment of mild to moderate active crohn's disease involving the ileum and/or the ascending colon

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

ORTIKOS family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic